By Aubrey Clark, Technical Advisor for Pharmaceutical Services, and Mohan P. Joshi, Principal Technical Advisor and Cluster Lead for Pharmaceutical Services On September 21st, global leaders attending this year’s United Nations General Assembly will discuss one of the most pressing global public health threats of our time: antimicrobial resistance (AMR). This AMR meeting is only the … Read more
Archive SIAPS News
Diagnostic and Treatment Guideline and the Pharmaceutical Formulary for Primary Health Facilities
On August 25, 2016, The National Health Service presented the Diagnostic and Treatment Guideline and the Pharmaceutical Formulary for Primary Health Facilities, aiming to improve the early diagnosis and timely treatment of the most important health problems affecting the Dominicans, including -among others- the opportunistic infections in HIV/AIDS patients. SIAPS supported the development of these documents by updating … Read more
SIAPS Launches Innovative Digital Health Tool in Georgia to Monitor Adverse Drug Reactions
In April 2015, the US Agency for International Development (USAID) and Janssen Therapeutics officially launched the bedaquiline donation initiative. As part of this initiative, Janssen committed to providing bedaquiline at no cost to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Bedaquiline is the first anti-TB medicine to be approved by the U.S. Food … Read more
Join SIAPS at the International AIDS Conference 2016 held in Durban
The SIAPS Program is committed to contributing to and achieving an AIDS-free generation by improving access to HIV diagnosis, care and treatment. At #AIDS2016, we will present seven poster presentations that showcase our support to national treatment programs using a pharmaceutical systems strengthening approach. Can’t attend AIDS 2016 in person? Follow us on Twitter at … Read more
SIAPS Focus on Data-Informed Decision Making: June 2016
[View the story “SIAPS Focus on Data-Informed Decision Making: June 2016” on Storify]
Bedaquiline Treatment Reaches 200 Patients in Georgia
Georgia is one of the first countries to benefit from the USAID‑Janssen Therapeutics bedaquiline (BDQ) donation program. Along with delamanid, BDQ is one of only two new TB medicines released to the market in over 40 years. These medicines are being used for the treatment of MDR-TB patients, as well as TB patients who have … Read more
SIAPS Focus on Pharmacovigilance: May 2016
The SIAPS May 2016 Storify includes web content on SIAPS technical leadership in pharmacovigilance across multiple online platforms. Check out the selection of website features, tweets, and other posts below. [View the story “SIAPS Focus on Pharmacovigilance: May 2016” on Storify]
SIAPS Presents on OSPSANTE and OSPSIDA at WHO Francophone Technical Briefing Seminar on Medicine Policy 2016
The World Health Organization Department of Essential Medicines and Health Products invited SIAPS to participate in its annual French Technical Briefing Seminar, held 9-13 May, in Geneva, Switzerland. The seminar, held every year since 1998, brings together experts working in the pharmaceutical and health sector programs in francophone countries, around current and topical issues related … Read more
SIAPS Joins EPN in Issuing Call to Action against Antimicrobial Resistance
Delegates at the Ecumenical Pharmaceutical Network (EPN) Forum 2016, agreed upon and issued a Call to Action against antimicrobial resistance during the biannual meeting, held 18-21 May 2016, in Tubingen, Germany. EPN, a partner of the USAID-funded SIAPS Program, issued the renewed call to action with support from SIAPS and other partners. The Call to … Read more
SIAPS Delivers Plenary Presentation on AMR and UHC at EPN Forum 2016
The EPN Forum 2016, held 18-21 May 2016, in Tubingen, Germany, convened EPN constituents and stakeholders to intensify the network’s focus on major challenges in the pharmaceutical sector, including antimicrobial resistance (AMR). The forum was a chance for stakeholders to exchange ideas, share knowledge and best practices, and chart an effective course of action to … Read more
